Genovior focuses on sterile injectable drugs and is one of the leading CDMO companies that spans across various technological fields:
small molecules
peptides
biopharmaceuticals.
Genovior provides comprehensive services from R&D to PIC/S GMP production for API and FDF drugs, with advanced facilities in National Science Park in Taiwan. Genovior has products in four main categories:
biopharmaceuticals
anticancer drugs
peptide drugs
sterile injectables
Genovior looks for licensing and CDMO opportunity and will be your reliable partner!
more >
Year of Establishment:
2015
Total Number of Staff:
100-500
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Service Provider,Manufacturer
R&D capacity:
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Asia,Middle East
Advantage Description: